Future Patient - Telerehabilitation of Atrial Fibrillation Patients
NCT ID: NCT04493437
Last Updated: 2021-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2019-12-02
2021-05-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Future Patient - Telerehabilitation of Patients With Atrial Fibrillation
NCT06101485
Atrial Fibrillation, Prevention and Rehabilitation
NCT06337045
Rehabilitation of Patients With Atrial Fibrillation
NCT03035539
Effect of Targeted Education for Atrial Fibrillation Patients
NCT03707873
A Precision Medicine Approach to the Prevention of Depression in Patients With Atrial Fibrillation
NCT07178691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Outcome measures:
To evaluate two concepts for telerehabilitation programs and technologies for patients with AF in order to see how these concepts can increase self-management for patients in their rehabilitation process. The following outcome measures are in focus:
Primary outcomes:
* Usability of technologies seen from patients' and healthcare professionals' perspectives
* Test and evaluation of the contents of telerehabilitation programs
Secondary outcomes:
* Measurements of clinical data
* Patients' and relatives' expectations for and experience with participation in the telerehabilitation program
* Healthcare professionals' experience with workflows and collaboration between each other in the telerehabilitation program
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telerehabilitation group A
Device: Telerehabilitation Blood pressure (iHealth Neo), weight (iHealth Lina), step counters(Fitbit Inspire \& Charge 3), sleep sensor (Emfit QS), tablet (iPad Air 2), and ECG recorder (AliveCor KardiaMobile).
Telerehabilitation
Blood pressure (iHealth Neo), weight (iHealth Lina), step counters(Fitbit Inspire \& Charge 3), sleep sensor (Emfit QS), tablet (iPad Air 2), and ECG recorder (AliveCor KardiaMobile).
Telerehabilitation group B
Device: Telerehabilitation + rehabilitation at health care center Telerehabilitation: Blood pressure (iHealth Neo), weight (iHealth Lina), step counters(Fitbit Inspire \& Charge 3), sleep sensor (Emfit QS), tablet (iPad Air 2), and ECG recorder (AliveCor KardiaMobile).
Rehabilitation at health care center: The rehabilitation will consist of four closed group sessions focusing on patient education. The groups will consist of both patients and relatives. The program at the health care center will not include any psychological tests or data control. Duration is 4 x 2 hours sessions over a period of 1 month.
Telerehabilitation
Blood pressure (iHealth Neo), weight (iHealth Lina), step counters(Fitbit Inspire \& Charge 3), sleep sensor (Emfit QS), tablet (iPad Air 2), and ECG recorder (AliveCor KardiaMobile).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telerehabilitation
Blood pressure (iHealth Neo), weight (iHealth Lina), step counters(Fitbit Inspire \& Charge 3), sleep sensor (Emfit QS), tablet (iPad Air 2), and ECG recorder (AliveCor KardiaMobile).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults ≥ 18 years; no upper age limit
* Patients living in Skive and Viborg Municipality
* Living at home and capable of caring for him/herself
* Basic computer skills or a relative with basic computer skills
Exclusion Criteria
* Lack of ability to cooperate
* Patient does not speak, read and understand Danish
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aage and Johanne Louis-Hansens Foundation
UNKNOWN
Laboratory of Welfare Technology, Department of Health Science and Technology, AAU
UNKNOWN
Viborg Regional Hospital
OTHER
Skive Healthcare Center
UNKNOWN
Viborg Healthcare Center
UNKNOWN
University of Aarhus
OTHER
Department of Photonics Engineering, Technical University of Denmark
UNKNOWN
Aalborg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Birthe Dinesen
Professor, PhD, Master in Political Science, RN, Head of Laboratory of Welfare Technology - Telehealth & Telerehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Cardiology, Viborg Regional Hospital
Viborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dinesen B, Dam Gade J, Skov Schacksen C, Spindler H, Eie Albertsen A, Dittmann L, Jochumsen M, Svenstrup Moller D. The Danish Future Patient Telerehabilitation Program for Patients With Atrial Fibrillation: Design and Pilot Study in Collaboration With Patients and Their Spouses. JMIR Cardio. 2021 Jul 19;5(2):e27321. doi: 10.2196/27321.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-20190059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.